Antibacterial drug discovery and development--SRI's 11th Annual Summit. Antibacterial trends and current research.
Silver
Lynn L
LL
LL Silver Consulting LLC, 3403 Park Place, Springfield, NJ 07081, USA. silverly@comcast.net
D000284:Administration, Oral; D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000737:chemistry / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D015195:Drug Design; D024881:Drug Resistance, Bacterial; D006801:Humans; D007262:Infusions, Intravenous; D015394:Molecular Structure; D010455:Peptides / Q000008:administration & dosage / Q000235:genetics / Q000627:therapeutic use*; D011743:Pyrimidines / Q000008:administration & dosage / Q000737:chemistry / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000235:genetics / Q000378:metabolism; D017334:Teicoplanin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000737:chemistry / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D010455:Peptides; D011743:Pyrimidines; D011994:Recombinant Proteins; C504857:plectasin; C486448:iclaprim; D017334:Teicoplanin; C469289:dalbavancin